PLXNB3 and Alzheimer disease: This idea is supported not only by data from the functional analyses of aOPCs in vitro and in vivo, but also by the data from the analyses of human AD brains, especially by the specific plexin-B3 immunoreactivity of SPs, one of the most important neuropathological hallmarks of AD.